Related Experiment Video
Updated: Sep 27, 2026
Establishment and Evaluation of a Risk Prediction Model for Pathological Escalation of Gastric Low-Grade Intraepithelial Neoplasia
Published on: February 16, 2024
Prevalence of Gastric Intestinal Metaplasia Among Patients with Active Helicobacter Pylori Infection Served by a
Aaron P Thrift1,2, Krishna Chandrasekhara3, Neda Zarrin-Khameh4,5
1Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. aaron.thrift@bcm.edu.
Background:
Gastric intestinal metaplasia (GIM) is a precursor of gastric cancer. Prior estimates of GIM prevalence in retrospective studies of U.S. populations may not be representative of true prevalence because gastric biopsies are not routinely performed for screening in the general population.
Methods:
Participants from a cross-sectional screening study of a safety-net patient population in Houston, Texas, who were Helicobacter pylori seropositive underwent endoscopy with systematic gastric mapping biopsies per Sydney protocol. Among participants with histopathologic evidence of active H. pylori, we calculated the prevalence of GIM overall and within subgroups. We additionally examined the prevalence of extensive (body involvement) and severe (Operative Link on GIM Assessment [OLGIM] stage III/IV) GIM.
Results:
We included data from 273 patients with mean age 47.4 years. Most patients were female (75.1%), Hispanic (92.3%), and first-generation immigrants (90.5%). Overall, 28.9% (95% confidence interval [CI] 23.6%-34.7%) of patients with active H. pylori had GIM, including 8.1% (95% CI 5.1%-11.9%) with extensive GIM. All participants with GIM had OLGIM stage I/II. Prevalence of GIM did not vary between sociodemographic groups. Prevalence of GIM was 29.0% (95% CI 23.4%-35.0%) among Hispanic patients and 28.6% (95% CI 11.3%-52.2%) among non-Hispanic patients. GIM prevalence among first-generation immigrants (28.7%; 95% CI 23.2%-34.4%) was similar to among second- and third-generation immigrants (30.8%; 95% CI 14.3%-51.8%).
Conclusions:
In a safety-net U.S. population, 28.9% of patients with active H. pylori infection had GIM. While GIM may improve after H. pylori eradication, prevalence of GIM is high in all sociodemographic subgroups in the setting of active H. pylori infection.
More Related Videos
03:33Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology
Published on: May 23, 2025
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
01:26Gastritis II: Pathophysiology
01:27Peptic Ulcer
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:24Peptic Ulcer Disease II: Pathophysiology